As of 2024-12-15, the Relative Valuation of Eupraxia Pharmaceuticals Inc (EPRX.TO) is 4.80 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 4.85 CAD, the upside of Eupraxia Pharmaceuticals Inc based on Relative Valuation is -1.0%.
The range of the Relative Valuation is 4.80 - 4.80 CAD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -3.7x - -3.7x | -3.7x |
| Fair Price | 4.80 - 4.80 | 4.80 |
| Upside | -1.0% - -1.0% | -1.0% |
| Date | P/E |
| 2024-11-29 | -3.68 |
| 2024-11-28 | -3.69 |
| 2024-11-27 | -3.61 |
| 2024-11-26 | -3.61 |
| 2024-11-25 | -3.80 |
| 2024-11-22 | -3.78 |
| 2024-11-21 | -3.65 |
| 2024-11-20 | -3.88 |
| 2024-11-19 | -3.55 |
| 2024-11-18 | -3.31 |
| 2024-11-15 | -3.38 |
| 2024-11-14 | -3.28 |
| 2024-11-13 | -3.01 |
| 2024-11-12 | -3.08 |
| 2024-11-11 | -3.18 |
| 2024-11-08 | -3.39 |
| 2024-11-07 | -3.40 |
| 2024-11-06 | -3.36 |
| 2024-11-05 | -3.41 |
| 2024-11-04 | -3.62 |
| 2024-11-01 | -3.31 |
| 2024-10-31 | -2.54 |
| 2024-10-30 | -2.60 |
| 2024-10-29 | -2.70 |
| 2024-10-28 | -2.66 |
| 2024-10-25 | -2.64 |
| 2024-10-24 | -2.62 |
| 2024-10-23 | -2.64 |
| 2024-10-22 | -2.62 |
| 2024-10-21 | -2.62 |
| 2024-10-18 | -2.70 |
| 2024-10-17 | -2.67 |
| 2024-10-16 | -2.62 |
| 2024-10-15 | -2.56 |
| 2024-10-11 | -2.54 |
| 2024-10-10 | -2.54 |
| 2024-10-09 | -2.43 |
| 2024-10-08 | -2.46 |
| 2024-10-07 | -2.61 |
| 2024-10-04 | -2.75 |
| 2024-10-03 | -2.72 |
| 2024-10-02 | -2.71 |
| 2024-10-01 | -2.70 |
| 2024-09-30 | -2.74 |
| 2024-09-27 | -2.67 |
| 2024-09-26 | -2.80 |
| 2024-09-25 | -2.76 |
| 2024-09-24 | -2.85 |
| 2024-09-23 | -2.91 |
| 2024-09-20 | -2.97 |